Approval · Notice of Compliance 2647 · 2001
TOBI: Notice of Compliance 2647
Issued April 4, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2647
- Date
- April 4, 2001
- Company
- Chiron Canada Limited
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Respiratory antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBI | 02239630 | Marketed |
Medicinal ingredients
- TOBRAMYCIN SULFATE 300 MG per 5ML